HRMY: Harmony Biosciences Holdings, Inc. Company Short-Term Debt
The market dynamics of Harmony Biosciences (HRMY) securities on the GURU.Markets platform demonstrate the 0.08 indicator. Harmony Biosciences minimizes drug supply disruptions through route variability and inventory management. Business growth relies on the popularity of Wakix and the regulator's approval of new diagnoses. Financial stability is based on the exclusive ownership rights to the core product, which ensures a steady stream of revenue from patients.
Analytical breakdowns for Harmony Corp (HRMY)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Debt to Equity Harmony Biosciences|HRMY - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Harmony Biosciences|HRMY - Company Total Debt|Debt to Book Capitalization Ratio Harmony Biosciences Holdings, Inc.|HRMY - Long-Term Debt|Company Short-Term Debt Harmony Biosciences|Quick Liquidity Indicator harmonybiosciences.com
- net income and valuation multiples indicators:
Initial company analysis:HRMY - Harmony Biosciences Holdings, Inc.
Short-term liabilities determine the current solvency of Harmony Biosciences (HRMY) when financing R&D projects. This metric aggregates all borrowed funds due within one year to measure liquidity risk. By analyzing the short-term debt trend, an investor assesses the company's ability to service its debts without selling assets. The stability of this indicator confirms financial resilience when hiring experts for molecule commercialization. Reducing this burden minimizes the probability of a cash crunch.
Main competitors
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|XENE: Company Short-Term Loans and Borrowings|Company Short-Term Debts VKTX|Company Short-Term Debts Supernus Pharmaceuticals, Inc. (SUPN)|Company Short-Term Debt Catalyst Pharmaceuticals Inc CPRX|Company Short-Term Loans and Borrowings DNLI|BHVN - Company Short-Term Debt|amylyx.com (AMLX) - Company Current Liabilities|Trevi Therapeutics, Inc. (TRVI) - Company Short-Term Debt|Short-Term Debt Praxis Precision Medicines Inc (PRAX)|Company Short-Term Debt Anavex Corp|Company Short-Term Indebtedness CBLL (CeriBell EEG)|Company Current Liabilities PRTA (Prothena)|ALEC - Short-Term Debt|Annexon - Company Current Liabilities|Company Short-Term Loans and Borrowings OMER|Neurogene Corp - Company Short-Term Debts|ACIU: Company Short-Term Debt|VYGR: Company Short-Term Debts|NMRA - Short-Term Debt Volume|Company Short-Term Debt Scilex|Short-Term Debt Tevogen Bio Holdings Inc. TVGN|Company Short-Term Debt Alpha Cognition (ACOG)|Short-Term Debt Volume cogrx.com|Company Short-Term Debts IKT (Inhibikase Therapeutics)|SAVA - Company Current Liabilities|Assertio Therapeutics - Company Short-Term Debts|Short-Term Debt Volume Coya Therapeutics, Inc. COYA|VTGN: Company Short-Term Debts|Short-Term Debt Ovid Therapeutics (OVID)|Company Short-Term Debt Acumen Pharmaceuticals|Company Short-Term Indebtedness CRVO (cervomed.com)|Company Short-Term Debts ATHE|Company Current Liabilities clene.com CLNN|Company Short-Term Debts PEPG (PepGen)|jupiterneurosciences.com (JUNS) - Short-Term Debt|RLMD - Company Short-Term Debt|Short-Term Debt Volume annovisbio.com ANVS|GRCE: Company Short-Term Debts|Firefly Neuroscience, Inc. - Company Short-Term Loans and Borrowings|Company Short-Term Debt ANEW Medical|NRSN: Company Short-Term Loans and Borrowings|Company Short-Term Debt Reviva Pharmaceuticals (RVPH)|Company Current Liabilities metaviatx.com MTVA|NeurAxis - Company Current Liabilities|Helius Medical Technologies, Inc. (HSDT) - Short-Term Debt|PASG - Company Short-Term Debt|NEUP (Neuphoria Therapeutics Inc.) - Company Short-Term Indebtedness|NERV: Company Short-Term Debts|Short-Term Debt athira.com (ATHA)|Company Current Liabilities ADXN|Company Short-Term Debts Alzamend|Company Short-Term Debt Cyclerion Therapeutics (CYCN)|PTIX (protagenic.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Pasithea Therapeutics Corp. KTTA|Cortigent Inc (CRGT) - Short-Term Debt|Avenue Therapeutics, Inc. - Company Short-Term Debts|Company Short-Term Loans and Borrowings BCLI (Brainstorm Cell Therapeutics Inc.)|CARA: Company Short-Term Debts|Chromocell (CHRO) - Company Short-Term Debts|Company Short-Term Debt Eliem Therapeutics, Inc.|ITCI: Company Short-Term Loans and Borrowings|Company Short-Term Debt Longboard Pharmaceuticals, Inc. (LBPH)|Company Current Liabilities Marinus Pharmaceuticals Inc MRNS|Company Short-Term Debt NKGen NKGN|NeuroBo Pharma (NRBO) - Short-Term Debt|SAGE - Company Short-Term Debt|SNPX (synaptogen.com) - Company Short-Term Indebtedness|TRVN (Trevena) - Company Current Liabilities|Short-Term Debt Vigil Neuroscience, Inc. (VIGL)|Company Current Liabilities WENA|CERE: Company Short-Term Loans and Borrowings